These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2143051)

  • 1. A phase I study of doxifluridine as a five-day stepped-dose continuous infusion.
    Olver IN; Reece PA; Bishop JF; Morris RG; Hillcoat BL; Guentert TW
    Am J Clin Oncol; 1990 Aug; 13(4):308-11. PubMed ID: 2143051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study of doxifluridine given by 5-day stepped-dose infusion.
    Reece PA; Olver IN; Morris RG; Bishop JF; Guentert TW; Hill HS; Hillcoat BL
    Cancer Chemother Pharmacol; 1990; 25(4):274-8. PubMed ID: 2136810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens.
    Bajetta E; Di Bartolomeo M; Somma L; Del Vecchio M; Artale S; Zunino F; Bignami P; Magnani E; Buzzoni R
    Eur J Cancer; 1997 Apr; 33(4):687-90. PubMed ID: 9274455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II clinical evaluation of doxifluridine.
    Hurteloup P; Armand JP; Cappelaere P; Metz R; Kerbrat P; Keiling R; Fumoleau P; Fargeot P; Schraub S; Bastit P
    Cancer Treat Rep; 1986 Jun; 70(6):731-7. PubMed ID: 2942245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma.
    Bajetta E; Di Bartolomeo M; Somma L; Moreschi M; Comella G; Turci D; Gebbia V; Scanni A; Bordogna G; Stampino CG
    Cancer; 1996 Nov; 78(10):2087-93. PubMed ID: 8918401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).
    Arteaga CL; Brown TD; Kuhn JG; Shen HS; O'Rourke TJ; Beougher K; Brentzel HJ; Von Hoff DD; Weiss GR
    Cancer Res; 1989 Aug; 49(16):4648-53. PubMed ID: 2743343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.
    Tetef ML; Synold TW; Chow W; Leong L; Margolin K; Morgan R; Raschko J; Shibata S; Somlo G; Yen Y; Groshen S; Johnson K; Lenz HJ; Gandara D; Doroshow JH
    Clin Cancer Res; 2001 Jun; 7(6):1569-76. PubMed ID: 11410492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer.
    Bajetta E; Colleoni M; Rosso R; Sobrero A; Amadori D; Comella G; Marangolo M; Scanni A; Lorusso V; Calabresi F
    Eur J Cancer; 1993; 29A(12):1658-63. PubMed ID: 8398289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors.
    Weiss GR; Kuhn JG; Rizzo J; Smith LS; Rodriguez GI; Eckardt JR; Burris HA; Fields S; VanDenBerg K; von Hoff DD
    Cancer Chemother Pharmacol; 1995; 35(5):397-402. PubMed ID: 7850921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
    Sasaki Y; Amano T; Morita M; Shinkai T; Eguchi K; Tamura T; Ohe Y; Kojima A; Saijo N
    Cancer Res; 1991 Mar; 51(5):1472-7. PubMed ID: 1997185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY
    Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of doxifluridine in advanced squamous cell carcinoma of the head and neck.
    Abele R; Kaplan E; Grossenbacher R; Schmid HJ; Cavalli F
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):333-6. PubMed ID: 6231185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma.
    Grem JL; McAtee N; Steinberg SM; Hamilton JM; Murphy RF; Drake J; Chisena T; Balis F; Cysyk R; Arbuck SG
    Cancer Res; 1993 Oct; 53(20):4828-36. PubMed ID: 8402669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of combination therapy with continuous-infusion PALA and continuous-infusion 5-FU.
    Weiss GR; Ervin TJ; Meshad MW; Schade D; Branfman AR; Bruni RJ; Chadwick M; Kufe DW
    Cancer Chemother Pharmacol; 1982; 8(3):301-4. PubMed ID: 7127661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II study.
    Falcone A; Pfanner E; Ricci S; Bertuccelli M; Cianci C; Carrai M; De Marco S; Ceribelli A; Barduagni M; Calabresi F
    Ann Oncol; 1994 Oct; 5(8):760-2. PubMed ID: 7826910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS; Mangalik A; Ferguson J; Elias L
    Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
    Abigerges D; Chabot GG; Armand JP; Hérait P; Gouyette A; Gandia D
    J Clin Oncol; 1995 Jan; 13(1):210-21. PubMed ID: 7799022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I-II study of oral doxifluridine plus radiotherapy in radiosensitive tumors of the pelvic region.
    Spagnesi S; Ducci F; Laddaga M; Falcone A; Conte PF; Pandolfi A; Stampino CG
    Tumori; 1993 Aug; 79(4):250-3. PubMed ID: 8249177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.
    Mani S; Rudin CM; Kunkel K; Holmlund JT; Geary RS; Kindler HL; Dorr FA; Ratain MJ
    Clin Cancer Res; 2002 Apr; 8(4):1042-8. PubMed ID: 11948111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.